Suppr超能文献

代谢综合征与非酒精性脂肪性肝病患儿肝组织学的关系。

Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.

机构信息

Departments of Medicine and Pediatrics, University of California, San Diego, San Diego, California, USA.

出版信息

Am J Gastroenterol. 2010 Sep;105(9):2093-102. doi: 10.1038/ajg.2010.152. Epub 2010 Apr 6.

Abstract

OBJECTIVES

Nonalcoholic steatohepatitis (NASH) is considered the hepatic manifestation of metabolic syndrome (MetS) among adults. Emerging data suggest that MetS may be associated with nonalcoholic fatty liver disease (NAFLD) in children as well. We sought to determine whether MetS or its component features are associated with specific histological features or severity of NAFLD.

METHODS

Children and adolescents aged 6-17 years enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) with clinical data obtained within 6 months of liver biopsy were included. MetS was defined as the presence of three or more of the following features as determined by application of age-adjusted normative values: central obesity, dyslipidemia, impaired fasting glucose, and elevated blood pressure. Liver biopsies were evaluated by the Pathology Committee of the NASH CRN.

RESULTS

Two hundred fifty four children were included in the analysis, of whom 65 (26%) met specified criteria for MetS. Among children with MetS, there is a higher proportion of females who were on average older in age and pubertal. The risk of MetS was greatest among those with severe steatosis (odds ratio (OR)=2.58 for grade 3 vs. grade 1 steatosis, P=0.001). The presence of hepatocellular ballooning was also significantly associated with MetS (OR=2.10, P=0.03). Those with advanced fibrosis (stage 3/4) had an OR for MetS of 3.21 (P=0.04) vs. those without fibrosis (stage 0). Borderline zone 1 or definite NASH patterns compared with "not NASH" were strongly associated with MetS (OR=4.44, P=0.005 and OR=4.07, P=0.002, respectively). The mean NAFLD Activity Score (NAS) was greater among children with MetS vs. those without (4.8 +/- 1.4 vs. 4.3 +/- 1.4, P=0.01). Central obesity was significantly associated with steatosis, fibrosis, hepatocellular ballooning, and NAFLD pattern. Insulin resistance was significantly associated with steatosis, fibrosis, hepatocellular ballooning, NAS, and NAFLD pattern.

CONCLUSIONS

MetS is common among children with NAFLD and is associated with severity of steatosis, hepatocellular ballooning, NAS, NAFLD pattern, and the presence of advanced fibrosis. Individual MetS features, particularly central obesity and insulin resistance, were also associated with severity of NAFLD. MetS features should be considered in children with NAFLD as individually and collectively they help identify children with more advanced disease.

摘要

目的

非酒精性脂肪性肝炎(NASH)被认为是成年人代谢综合征(MetS)的肝脏表现。新出现的数据表明,MetS 也可能与儿童的非酒精性脂肪性肝病(NAFLD)有关。我们试图确定 MetS 或其组成特征是否与 NAFLD 的特定组织学特征或严重程度相关。

方法

我们纳入了年龄在 6-17 岁之间、在肝活检后 6 个月内获得临床数据的非酒精性脂肪性肝炎临床研究网络(NASH CRN)的儿童和青少年。MetS 的定义为应用年龄校正的正常参考值确定的以下三种或三种以上特征存在:中心性肥胖、血脂异常、空腹血糖受损和血压升高。肝活检由 NASH CRN 的病理委员会进行评估。

结果

在 254 名接受分析的儿童中,有 65 名(26%)符合 MetS 的特定标准。在患有 MetS 的儿童中,女性比例较高,且平均年龄较大且处于青春期。在有严重脂肪变性的儿童中,MetS 的风险最大(等级 3 与等级 1 脂肪变性的比值比(OR)=2.58,P=0.001)。肝细胞气球样变也与 MetS 显著相关(OR=2.10,P=0.03)。纤维化程度为 3/4 期(分期)的患儿 MetS 的比值比(OR)为 3.21(P=0.04),而无纤维化(分期 0 期)的患儿为 1.0。边缘区 1 或明确的 NASH 模式与“非 NASH”相比,与 MetS 强烈相关(OR=4.44,P=0.005 和 OR=4.07,P=0.002)。患有 MetS 的儿童的 NAFLD 活动评分(NAS)平均值高于无 MetS 的儿童(4.8 +/- 1.4 与 4.3 +/- 1.4,P=0.01)。中心性肥胖与脂肪变性、纤维化、肝细胞气球样变和 NAFLD 模式显著相关。胰岛素抵抗与脂肪变性、纤维化、肝细胞气球样变、NAS 和 NAFLD 模式显著相关。

结论

MetS 在患有 NAFLD 的儿童中很常见,并且与脂肪变性、肝细胞气球样变、NAS、NAFLD 模式和晚期纤维化的严重程度相关。MetS 的个别特征,特别是中心性肥胖和胰岛素抵抗,也与 NAFLD 的严重程度相关。在患有 NAFLD 的儿童中应考虑 MetS 特征,因为它们单独和集体有助于识别更严重疾病的儿童。

相似文献

1
Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
Am J Gastroenterol. 2010 Sep;105(9):2093-102. doi: 10.1038/ajg.2010.152. Epub 2010 Apr 6.
2
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.
JAMA Netw Open. 2019 Oct 2;2(10):e1912565. doi: 10.1001/jamanetworkopen.2019.12565.
3
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Metabolism. 2016 Aug;65(8):1080-6. doi: 10.1016/j.metabol.2015.11.008. Epub 2015 Dec 2.
9
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.
World J Gastroenterol. 2011 Jul 14;17(26):3082-91. doi: 10.3748/wjg.v17.i26.3082.

引用本文的文献

1
MAFLD outperforms NAFLD in identifying metabolic dysfunction in U.S. adolescents: a NHANES 2017-2020 analysis.
BMC Gastroenterol. 2025 Aug 25;25(1):617. doi: 10.1186/s12876-025-04170-w.
2
Evaluating Pediatric NAFLD with Controlled Attenuation Parameter: A Comprehensive Narrative Review.
Diagnostics (Basel). 2025 Jan 27;15(3):299. doi: 10.3390/diagnostics15030299.
4
Pediatric MASLD: current understanding and practical approach.
Eur J Pediatr. 2024 Nov 19;184(1):29. doi: 10.1007/s00431-024-05848-1.
5
NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review.
Int J Mol Sci. 2024 Aug 2;25(15):8462. doi: 10.3390/ijms25158462.
6
Diabetes mellitus-Progress and opportunities in the evolving epidemic.
Cell. 2024 Jul 25;187(15):3789-3820. doi: 10.1016/j.cell.2024.06.029.
7
Non-alcoholic Fatty Liver in Children and Adolescents in Saudi Arabia.
Cureus. 2023 Oct 2;15(10):e46380. doi: 10.7759/cureus.46380. eCollection 2023 Oct.
9
Skeptical Look at the Clinical Implication of Metabolic Syndrome in Childhood Obesity.
Children (Basel). 2023 Apr 17;10(4):735. doi: 10.3390/children10040735.
10
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.
Int J Mol Sci. 2023 Apr 24;24(9):7791. doi: 10.3390/ijms24097791.

本文引用的文献

1
Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.
Contemp Clin Trials. 2010 Jan;31(1):62-70. doi: 10.1016/j.cct.2009.09.001. Epub 2009 Sep 15.
2
Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.
Gastroenterology. 2008 Dec;135(6):1961-1971.e2. doi: 10.1053/j.gastro.2008.08.050. Epub 2008 Sep 3.
3
Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease.
Circulation. 2008 Jul 15;118(3):277-83. doi: 10.1161/CIRCULATIONAHA.107.739920. Epub 2008 Jun 30.
4
Relationship between body mass index and metabolic syndrome risk factors among US 8- to 14-year-olds, 1999 to 2002.
J Pediatr. 2008 Aug;153(2):215-21. doi: 10.1016/j.jpeds.2008.03.002. Epub 2008 Apr 18.
5
Metabolic syndrome and its association with diet and physical activity in US adolescents.
J Am Diet Assoc. 2008 Feb;108(2):276-86; discussion 286. doi: 10.1016/j.jada.2007.10.049.
6
Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002.
J Pediatr. 2008 Feb;152(2):165-70. doi: 10.1016/j.jpeds.2007.06.004. Epub 2007 Oct 22.
7
Diagnosis and classification of diabetes mellitus.
Diabetes Care. 2008 Jan;31 Suppl 1:S55-60. doi: 10.2337/dc08-S055.
8
Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.
Int J Obes (Lond). 2008 Feb;32(2):381-7. doi: 10.1038/sj.ijo.0803711. Epub 2007 Dec 18.
10
Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.
Gastroenterology. 2007 Dec;133(6):1814-20. doi: 10.1053/j.gastro.2007.08.077. Epub 2007 Sep 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验